ZACKSยท2025-09-19 13:15Core Insights - The article emphasizes the importance of sales growth over traditional earnings metrics for evaluating stocks, especially in volatile market conditions [2][3][10] - A selection of stocks with strong sales growth and cash flow is recommended, including Universal Health Services, Methanex, Arista Networks, Voya Financial, and Maximus [2][10][12] Sales Growth as a Metric - Sales growth is preferred as it reflects actual demand for a company's products or services, providing better visibility into the durability of the business model [3][5] - Companies that can expand their sales during economic stress demonstrate pricing power and competitive advantages [3][5] Earnings Limitations - Earnings can be misleading due to one-off charges, cost-cutting, and accounting adjustments, making them less reliable indicators of a company's trajectory [4] Cash Flow and Financial Flexibility - Sustained sales growth leads to stronger cash flows, allowing companies to reinvest in innovation, expand markets, or return capital to shareholders without excessive debt reliance [5] Stock Selection Criteria - Stocks are shortlisted based on criteria such as 5-Year Historical Sales Growth greater than industry average and Cash Flow exceeding $500 million [6] - Additional metrics include P/S Ratio, % Change in Sales Estimate Revisions, Operating Margin, Return on Equity, and Zacks Rank [7][8][9] Recommended Stocks - Universal Health Services (UHS) is expected to have a sales growth rate of 8.5% in 2025 and holds a Zacks Rank of 2 [11][12] - Methanex (MEOH) anticipates a sales growth rate of 5.6% in 2025 with a Zacks Rank of 1 [12] - Arista Networks (ANET) is projected to achieve a sales growth of 25.4% in 2025 and has a Zacks Rank of 2 [13] - Voya Financial (VOYA) expects a sales growth of 16.1% in 2025, also holding a Zacks Rank of 2 [14] - Maximus (MMS) forecasts a sales growth of 2.7% in fiscal 2025 and has a Zacks Rank of 1 [15]